Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,600 | -13,830 | -39,485 | -26,767 | -17,490 |
| Depreciation Amortization | 988 | 445 | 1,606 | 1,198 | 833 |
| Income taxes - deferred | 95 | 47 | 780 | 492 | 448 |
| Accounts receivable | -602 | -25 | -573 | -108 | 359 |
| Other Working Capital | -2,255 | -1,997 | 1,729 | 146 | -155 |
| Other Operating Activity | 5,868 | 4,107 | 8,842 | 5,301 | 2,879 |
| Operating Cash Flow | $-22,506 | $-11,254 | $-27,102 | $-19,738 | $-13,126 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -920 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,439 | -1,240 | -2,692 | -949 | -269 |
| Net Acquisitions | 51 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-3,308 | $-1,240 | $-2,692 | $-949 | $-269 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,341 | 958 | 1,041 | 710 | 221 |
| Debt Repayment | -106 | -53 | -202 | -150 | -93 |
| Common Stock Issued | 11,754 | 6,977 | 61,915 | 23,730 | 14,354 |
| Other Financing Activity | -443 | -163 | -565 | -395 | -103 |
| Financing Cash Flow | $12,546 | $7,719 | $62,190 | $23,895 | $14,379 |
| Beginning Cash Position | 46,134 | 46,134 | 13,738 | 13,738 | 13,738 |
| End Cash Position | 32,865 | 41,360 | 46,134 | 16,946 | 14,723 |
| Net Cash Flow | $-13,269 | $-4,774 | $32,396 | $3,209 | $985 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,506 | -11,254 | -27,102 | -19,738 | -13,126 |
| Capital Expenditure | -2,439 | -1,240 | -2,692 | -949 | -269 |
| Free Cash Flow | -24,946 | -12,493 | -29,793 | -20,686 | -13,394 |